Clinical Trial Update: Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

This document reports the completion of a clinical trial evaluating Boston Scientific's Cryoballoon ablation system for symptomatic drug-refractory paroxysmal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Cryoballoon ablation system (cryoballoon ablation catheter)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2023-12-07